FDA has access from what I understand at all stages of the trial. They have the power to go in and look at any data prior to an official interim results. It’s logical to think they know from our very large number of EIND patients that Leronlimab works it was saving many of the worst condition patients, most importantly the FDA knows the drugs is Super Safe 64% reduction in SAE unheard of. Risk benefit analysis alone will get MHRA Approval and FDA Approval. Remember bar is set very low Remshamer, and Plasma which didn’t even have a controlled study to see if efficient at all or safe. Leronlimab has already shown improvement at day 3 in mild moderate and Severe Critical. The wrtings on the wall and now paints dry just sit back and enjot share price sky rocket next week. If shorts want to get burned to make a couple pennies Tom let them Get burned.